Hodgkin's lymphoma following treatment with etanercept in ankylosing spondylitis

Rheumatology International

Volumn 28, Issue 2, 2007, Pages 185-187

  Aksu, Kenan ^a   Donmez, Ayhan ^a   Ertan, Yesim ^a   Keser, Gokhan ^a   Inal, Vedat ^a   Oder, Gonca ^a   Tombuloglu, Murat ^a   Kabasakal, Yasemin ^a   Doganavsargil, Eker ^a  

^a EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Ankylosing spondylitis; Etanercept; Hodgkin's lymphoma

Indexed keywords

BLEOMYCIN; CARBOPLATIN; CORTICOSTEROID; DACARBAZINE; DOXORUBICIN; ETANERCEPT; ETOPOSIDE; IFOSFAMIDE; INDOMETACIN; ISONIAZID; METHOTREXATE; SALAZOSULFAPYRIDINE; VINCRISTINE;

ADULT; ANKYLOSING SPONDYLITIS; ARTICLE; BIOPSY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RISK; CASE REPORT; CELL TYPE; FEMALE; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PATHOLOGY; PRIORITY JOURNAL;

ADULT; ANTIRHEUMATIC AGENTS; HODGKIN DISEASE; HUMANS; IMMUNOGLOBULIN G; MALE; RECEPTORS, TUMOR NECROSIS FACTOR; SPONDYLITIS, ANKYLOSING; TREATMENT OUTCOME;

EID: 36148986073     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-007-0391-9     Document Type: Article

References (10)

1. Antoni C, Braun J (2002) Side effects of anti-TNF therapy: current knowledge. Clin Exp Rheumatol 6(Suppl 28):S152-S157
2. Desai SB, Furst DE (2006) Problems encountered during anti-tumour necrosis factor therapy. Best Pract Res Clin Rheumatol 4:757-790
3. Bernatsky S, Ramsey-Goldman R, Clarke A (2006) Malignancy and autoimmunity. Curr Opin Rheumatol 8:129-134
4. Askling J, Klareskog L, Blomqvist P, Fored M, Feltelius N (2006) Risk for malignant lymphoma in ankylosing spondylitis: a nationwide Swedish case-control study. Ann Rheum Dis 65:1184-1187
5. Jantunen E, Myllykangas-Luosujarvi R, Kaipiainen-Seppanen O, Nousiainen T (2000) Autologous stem cell transplantation in a lymphoma patient with a long history of ankylosing spondylitis. Rheumatology (Oxford) 5:563-564
6. Khan SY, Hutchinson DG (2004) Primary synovial non-Hodgkin's lymphoma in association with ankylosing spondylitis. Rheumatology (Oxford) 43:391
7. Brown SL, Greene MH, Gershon SK, Edwards ET, Braun MM (2002) Tumor necrosis factor antagonist therapy and lymphoma development: twenty-six cases reported to the Food and Drug Administration. Arthritis Rheum 46:3151-3158
8. Thomas RK, Wolf J, Diehl V (2004) Part I-Hodgkin's lymphoma-molecular biology of Hodgkin and Reed-Sternberg cells. Lancet Oncol 5:11-18
9. Weiss LM, Strickler JG, Warnke RA, et al (1987) Ebstein-Barr viral DNA in tissues of Hodgkin's disease. Am J Pathol 129:86-91
10. Wolfe F, Michaud K (2004) Lymphoma in rheumatoid arthritis: the effect of methotrexate and anti-tumor necrosis factor therapy in 18,572 patients. Arthritis Rheum 50:1740-1751